Media
Talk to Our Care TeamStudy of CAR T-Cell therapy trial in India, in leukaemia patients, shows 73% response rate
The Hindu Bureau
17 Mar 2025Indian-Made Gene Therapy For Blood Cancer Shows 73% Response Rate In Clinical Trials
NDTV NEWS
17 Mar 2025India’s blood cancer gene therapy shows 73% response rate in clinical trials: Report
Hindustan Times
17 Mar 2025Fight Against Cancer: India’s 1st CAR-T Cell Therapy Shows 73% Success Rate; Know Other Advantages
OdishaBytes
17 Mar 2025Gene therapy for blood cancer shows 73 per cent response rate in clinical trials
The Economic Times
17 Mar 2025Affordable CAR T-Cell Therapy for Blood Cancers: ImmunoACT’s NexCAR19
MedIndia
13 Feb 2025In a first, Safdarjung Hospital uses CAR T-cell therapy to treat cancer patient
The Indian Express
25 Jan 2025T-Cell Therapy For Cancer: How effective is Tcell therapy against cancer? With which Safdarjung Hospital gave a new life to the patient
ABP News
24 Jan 2025ImmunoACT’s Collaboration with IIT Bombay and Tata Memorial
National Cancer Institute (USA)
07 Jan 2025